Insulog is a handy little smart device that snaps onto all insulin pens. It detects and shows the last intake time and dose andautomatically synchronizing it to an app, where you can review & store data, easily sharing it with the medical team. Since over 95% of patients use disposable insulin pens, this provides a competitive advantage with comparison to companies providing reusable pens. In addition to this, Insulog is the first device to automatically record the insulin dose in real time. This lets patients to keep track of their insulin injections at any time, everywhere.
The total cost of European healthcare was approximately €1.48 trillion in 2014, of which approximately 12% is attributed to diabetes18. In particular, complications of a missing insulin injection represent a huge burden for the healthcare systems. For example, every year in the USA, about 282,000 emergency room visits for adults had hypoglycemia19 (low sugar level in bloodstream) as the first-listed diagnosis and diabetes as secondary diagnosis20. Most of these visits lead to hospitalization. Indeed, for diabetic patients the rate of hospital admissions from the emergency room is over four times greater than the average. Hospitalization represents the biggest share of the direct costs associated with diabetes care. It implies admission to hospital, laboratory analysis, the work of the medical staff and specific therapies. The average emergency visit cost of a diabetic patient eventually results three times higher than any other visit21. With the help of Insulog, insulin uncertainties can be reduced. This reduces emergency room visits and hospitalizations related to diabetes‟ complications and significant decrease in medical costs (around 60% of global diabetes costs22). An equivalent cost saving of at least €106.56 billion every year. In addition, Insulog has discussed the potential impact of the device with various stakeholders including patients and representatives from healthcare industries. These discussions assisted the company in identifying the main factors influencing their willingness to pay for the Insulog system
